학술논문

Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Document Type
Article
Source
ACR Open Rheumatology; May2024, Vol. 6 Issue 5, p304-311, 8p
Subject
THERAPEUTIC use of monoclonal antibodies
PSORIATIC arthritis
T-test (Statistics)
PROBABILITY theory
VISUAL analog scale
FATIGUE (Physiology)
TREATMENT duration
TREATMENT effectiveness
DESCRIPTIVE statistics
MONOCLONAL antibodies
LONGITUDINAL method
PAIN
QUALITY of life
RESEARCH
HEALTH outcome assessment
SPONDYLOARTHROPATHIES
DATA analysis software
CONFIDENCE intervals
MEDICAL needs assessment
RHEUMATOLOGISTS
Language
ISSN
25785745
Abstract
Copyright of ACR Open Rheumatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)